We are live on ! Find out more
ABMD

Abiomed Inc
ABMD

Delisted

ABMD was delisted on the 21st of December, 2022.

Back to rankings

527 hedge funds and large institutions have $16B invested in Abiomed Inc in 2018 Q2 according to their latest regulatory filings, with 153 funds opening new positions, 157 increasing their positions, 171 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

428% more first-time investments, than exits

New positions opened: 153 | Existing positions closed: 29

40% more funds holding in top 10

Funds holding in top 10: 15 → 21 (+6)

40% more capital invested

Capital invested by funds: $11.5B → $16B (+$4.55B)

30% more funds holding

Funds holding: 405 → 527 (+122)

8% less repeat investments, than reductions

Existing positions increased: 157 | Existing positions reduced: 171

21% less call options, than puts

Call options by funds: $167M | Put options by funds: $212M

Holders
527
Holders Change
+122
Holders Change %
+30.12%
% of All Funds
12.07%
Holding in Top 10
21
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+40%
% of All Funds
0.48%
New
153
Increased
157
Reduced
171
Closed
29
Calls
$167M
Puts
$212M
Net Calls
-$45.4M
Net Calls Change
-$39.3M

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$297M
2
Two Sigma Advisers
Two Sigma Advisers
New York
+$210M
3
State Street
State Street
Massachusetts
+$158M
4
Renaissance Technologies
Renaissance Technologies
New York
+$146M
5
Two Sigma Investments
Two Sigma Investments
New York
+$138M

Top Sellers

1
BlackRock
BlackRock
New York
-$315M
2
Winslow Capital Management
Winslow Capital Management
Minnesota
-$284M
3
PAI
Palo Alto Investors
California
-$165M
4
William Blair Investment Management
William Blair Investment Management
Illinois
-$154M
5
American Century Companies
American Century Companies
Missouri
-$136M
Name Holding Trade Value Shares
Change 		Change in
Stake
EWM
526
Essex Woodlands Management
Texas
– -$58.7M -201,818 Closed
ACH
527
ArrowMark Colorado Holdings
Colorado
– -$36.4M -125,007 Closed
Jennison Associates
528
Jennison Associates
New York
– -$16M -55,032 Closed
Arrowstreet Capital
529
Arrowstreet Capital
Massachusetts
– -$12M -41,100 Closed
BCM
530
BlueCrest Capital Management
Jersey
– -$8.07M -27,737 Closed
First Manhattan
531
First Manhattan
New York
– -$7.6M -26,117 Closed
Loomis, Sayles & Company
532
Loomis, Sayles & Company
Massachusetts
– -$6.4M -21,989 Closed
QIM
533
Quantitative Investment Management
Virginia
– -$3.67M -12,600 Closed
GIM
534
Granahan Investment Management
Massachusetts
– -$3.58M -12,317 Closed
CCM
535
Chilton Capital Management
Texas
– -$2.72M -9,451 Closed
TCM
536
Tekla Capital Management
Massachusetts
– -$1.9M -6,514 Closed
AGM
537
Alpine Global Management
New York
– -$1.55M -5,317 Closed
MFS
538
Madrona Financial Services
Washington
– -$1.04M -3,565 Closed
B
539
Barings
North Carolina
– -$917K -3,150 Closed
SCM
540
Shelton Capital Management
Colorado
– -$785K -2,697 Closed
WAM
541
Wolverine Asset Management
Illinois
– -$730K -2,510 Closed
MS
542
Maven Securities
Jersey
– -$655K -2,250 Closed
IR
543
Invictus RG
Bermuda
– -$354K -1,217 Closed
RRC
544
Relaxing Retirement Coach
Massachusetts
– -$291K -1,000 Closed
DC
545
Davenport & Co
Virginia
– -$207K -712 Closed
MA
546
Mutual Advisors
Nebraska
– -$206K -707 Closed
WF
547
WealthTrust Fairport
Ohio
– -$145K -500 Closed
SWP
548
Stratos Wealth Partners
Ohio
– -$118K -404 Closed
HFP
549
Holistic Financial Partners
Indiana
– -$62K -212 Closed
CG
550
Cutler Group
California
– -$72.5K -200 Closed
19 20 21
22
23

ABMD Hedge Fund Activity: Q2 2018 in Review

527 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q2 2018, worth a combined $16B — up 40% from $11.5B a quarter earlier.

Buyers outnumbered sellers: 153 funds opened new ABMD positions and 29 closed out — a net gain of 124 holders — while 157 added to existing stakes and 171 trimmed.

The largest buyer was Vanguard Group, adding an estimated $297M. The largest seller was BlackRock, cutting an estimated $315M.

  • 527 institutional investors held Abiomed Inc (ABMD) as of Q2 2018, up from 405 in Q1 2018.
  • Funds reported $16B of Abiomed Inc stock for Q2 2018, up 40% quarter-over-quarter.
  • 153 funds opened new Abiomed Inc positions in Q2 2018 and 29 closed out, a net change of +124 holders.
  • The largest Abiomed Inc buyer in Q2 2018 was Vanguard Group, an estimated $297M added.
  • The largest Abiomed Inc seller in Q2 2018 was BlackRock, an estimated $315M sold.

Based on aggregated 13F filings for Q2 2018.